Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T26859 |
BMS-8
|
PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
BMS-8 抑制PD-1/PD-L1相互作用(IC50:7.2 μM)。它能够直接与 PD-L1 结合,促使形成 PD-L1 同源二聚体,进而阻断 PD-L1 与 PD-1 的相互作用。 | |||
T30531L |
BMS-561392 Formic acid
BMS-561392 Formic acid(611227-74-8 Free base) |
MMP | Proteases/Proteasome |
BMS-561392 Formic acid 是 TACE 的选择性抑制剂,可降低 TNFalpha 水平。 | |||
T10962 |
Dasatinib-d8
BMS-354825 D8 |
Others | Others |
Dasatinib D8 is deuterium-labeled dasatinib. Dasatinib is a dual Bcr-Abl and Src family tyrosine kinase inhibitor. | |||
T71972 | N-Fmoc-8-aminooctanoic acid | ||
N-Fmoc-8-aminooctanoic acid can be used as a PROTAC linker in the synthesis of PROTACs. N-Fmoc-8-aminooctanoic acid is an alkane chian with terminal Fmoc-protected amine and carboxylic acid groups. The Fmoc group can be deprotected under basic condition to obtain the free amine which can be used for further conjugations. The terminal carboxylic acid can react with primary amine groups in the presence of activators (e.g. EDC, or HATU) to form a stable amide bond. | |||
T4598 |
BMS-5
BMS5,LIMKi 3 |
LIM Kinase | Cell Cycle/Checkpoint |
BMS-5 (LIMKi 3) 是一种有效的 LIMK 抑制剂,抑制LIMK1和LIMK2的IC50分别为 7 nM 和 8 nM。 | |||
T5398 |
BMS 599626 2HCl (873837-23-1(HCl))
AC480 dihydrochloride |
HER | Angiogenesis; JAK/STAT signaling; Tyrosine Kinase/Adaptors |
BMS 599626 2HCl (873837-23-1(HCl)) (AC480 dihydrochloride) 是 HER1 和 HER2 的选择性抑制剂(IC50:20 nM 和 30 nM),对 HER4 的效力降低约 8 倍,对 Lck、VEGFR2、c-Kit、MET 等的效力降低 100 倍以上。 | |||
T2545 |
Lomitapide Mesylate
甲磺酸洛美他派,BMS-201038 mesylate,AEGR-733 mesylate |
CETP | Metabolism |
Lomitapide Mesylate (BMS-201038 mesylate) 是一种高效MTP 蛋白抑制剂,其体外IC50值为8 nM。 | |||
T3146 |
BMS-202
PD1-PDL1 inhibitor 2,PD-1/PD-L1 inhibitor 2 |
Apoptosis; PD-1/PD-L1 | Apoptosis; Cell Cycle/Checkpoint; Immunology/Inflammation |
BMS-202 (PD1-PDL1 inhibitor 2) 是一种非肽类 PD-1/PD-L 复合物抑制剂,其 IC50为 18 nM,KD 为 8 μM。它与 PD-L1 直接结合并阻断人类 PD-1/PD-L 的相互作用,具有抗肿瘤活性。 |